Background/Objectives: Chronic myeloid leukemia (CML) is characterized by the presence of the BCR::ABL1 fusion gene, most commonly in the e14a2 or e13a2 variants. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.